Tiziana Life Sciences (TLSA) Current Assets (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Current Assets of $8.6 million for Q4 2025, up 13.91% year-over-year from $7.5 million in Q4 2024, and down 32.75% quarter-over-quarter from $12.7 million in Q2 2025.
Tiziana Life Sciences (TLSA) Current Assets (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Current Assets history runs 9 years deep, the most recent figure standing at $8.6 million for Q4 2025.
- In Q4 2025, Current Assets rose 13.91% year-over-year to $8.6 million; the TTM figure through Dec 2025 stood at $8.6 million (up 13.91% YoY), while the FY2025 annual figure was $8.6 million, up 13.91% from the prior year.
- Current Assets for Q4 2025 stood at $8.6 million, down from $12.7 million in the prior quarter.
- The five-year high for Current Assets was $57.2 million in Q2 2021, with the low at $7.3 million in Q4 2023.
- The 5-year median for Current Assets is $13.9 million (2023), against an average of $22.1 million.
- The sharpest annual moves came in 2021 and 2023: Current Assets jumped 362.03% in 2021, then plunged 69.78% in 2023.
- Tiziana Life Sciences' Current Assets stood at $48.7 million in 2021, then slumped by 50.12% to $24.3 million in 2022, then slumped by 69.78% to $7.3 million in 2023, then rose by 2.33% to $7.5 million in 2024, then rose by 13.91% to $8.6 million in 2025.
- Business Quant data shows TLSA's Current Assets at $8.6 million in Q4 2025, $12.7 million in Q2 2025, and $7.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 8.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.55 Mn |
| Jun 30, 2025 | 12.72 Mn |
| Dec 31, 2024 | 7.51 Mn |
| Jun 30, 2024 | 7.75 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Jun 30, 2023 | 15.18 Mn |
| Dec 31, 2022 | 24.28 Mn |
| Jun 30, 2022 | 32.32 Mn |
| Dec 31, 2021 | 48.68 Mn |
| Jun 30, 2021 | 57.15 Mn |
| Dec 31, 2020 | 67.88 Mn |
| Jun 30, 2020 | 12.37 Mn |
| Dec 31, 2019 | 1.47 Mn |
| Jun 30, 2019 | 1.95 Mn |
| Dec 31, 2018 | 6.71 Mn |
| Jun 30, 2018 | 1.48 Mn |
| Dec 31, 2017 | 2.41 Mn |